C-reactive protein in healthy subjects: associations with obesity, insulin resistance, and endothelial dysfunction: a potential role for cytokines originating from adipose tissue?

C-reactive protein, a hepatic acute phase protein largely regulated by circulating levels of interleukin-6, predicts coronary heart disease incidence in healthy subjects. We have shown that subcutaneous adipose tissue secretes interleukin-6 in vivo. In this study we have sought associations of levels of C-reactive protein and interleukin-6 with measures of obesity and of chronic infection as their putative determinants. We have also related levels of C-reactive protein and interleukin-6 to markers of the insulin resistance syndrome and of endothelial dysfunction. We performed a cross-sectional study in 107 nondiabetic subjects: (1) Levels of C-reactive protein, and concentrations of the proinflammatory cytokines interleukin-6 and tumor necrosis factor-alpha, were related to all measures of obesity, but titers of antibodies to Helicobacter pylori were only weakly and those of Chlamydia pneumoniae and cytomegalovirus were not significantly correlated with levels of these molecules. Levels of C-reactive protein were significantly related to those of interleukin-6 (r=0.37, P<0.0005) and tumor necrosis factor-alpha (r=0.46, P<0.0001). (2) Concentrations of C-reactive protein were related to insulin resistance as calculated from the homoeostasis model assessment model, blood pressure, HDL, and triglyceride, and to markers of endothelial dysfunction (plasma levels of von Willebrand factor, tissue plasminogen activator, and cellular fibronectin). A mean standard deviation score of levels of acute phase markers correlated closely with a similar score of insulin resistance syndrome variables (r=0.59, P<0.00005), this relationship being weakened only marginally by removing measures of obesity from the insulin resistance score (r=0.53, P<0.00005). These data suggest that adipose tissue is an important determinant of a low level, chronic inflammatory state as reflected by levels of interleukin-6, tumor necrosis factor-alpha, and C-reactive protein, and that infection with H pylori, C pneumoniae, and cytomegalovirus is not. Moreover, our data support the concept that such a low-level, chronic inflammatory state may induce insulin resistance and endothelial dysfunction and thus link the latter phenomena with obesity and cardiovascular disease.

[1]  P. Sorlie,et al.  Cohort study of cytomegalovirus infection as a risk factor for carotid intimal-medial thickening, a measure of subclinical atherosclerosis. , 1996, Circulation.

[2]  M. Laakso,et al.  Association of Chlamydia pneumoniae and acute coronary heart disease events in non-insulin dependent diabetic and non-diabetic subjects in Finland. , 1996, European heart journal.

[3]  P. O'Brien.  Procedures for comparing samples with multiple endpoints. , 1984, Biometrics.

[4]  J. Amiral,et al.  Design and validation of a new immunoassay for soluble forms of thrombomodulin and studies on plasma. , 1994, Hybridoma.

[5]  A. Cerami,et al.  Lipoprotein lipase suppression in 3T3-L1 cells by an endotoxin-induced mediator from exudate cells. , 1982, Proceedings of the National Academy of Sciences of the United States of America.

[6]  B. Spiegelman,et al.  Reduced tyrosine kinase activity of the insulin receptor in obesity-diabetes. Central role of tumor necrosis factor-alpha. , 1994, The Journal of clinical investigation.

[7]  P. Ridker,et al.  Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. , 1997, The New England journal of medicine.

[8]  J. Yudkin,et al.  Evidence of impaired glomerular charge selectivity in nondiabetic subjects with microalbuminuria: relevance to cardiovascular disease. , 1996, Arteriosclerosis, thrombosis, and vascular biology.

[9]  J. Yudkin,et al.  Associations of urinary albumin excretion rate with vascular disease in europid nondiabetic subjects. , 1994, Journal of diabetes and its complications.

[10]  Alexander Rw.  Inflammation and Coronary Artery Disease , 1994 .

[11]  W. Sluiter,et al.  Association of plasma fibrinogen levels with coronary artery disease, smoking and inflammatory markers. , 1996, Atherosclerosis.

[12]  D. Strachan,et al.  C Reactive protein and its relation to cardiovascular risk factors: a population based cross sectional study , 1996, BMJ.

[13]  R. Simsolo,et al.  The expression of tumor necrosis factor in human adipose tissue. Regulation by obesity, weight loss, and relationship to lipoprotein lipase. , 1995, The Journal of clinical investigation.

[14]  J. Ingerslev.  A sensitive ELISA for von Willebrand factor (vWf:Ag). , 1987, Scandinavian journal of clinical and laboratory investigation.

[15]  B. Spiegelman,et al.  Differential Regulation of the p80 Tumor Necrosis Factor Receptor in Human Obesity and Insulin Resistance , 1997, Diabetes.

[16]  T. van der Poll,et al.  Tumor Necrosis Factor Induces von Willebrand Factor Release in Healthy Humans , 1992, Thrombosis and Haemostasis.

[17]  M. Ernst,et al.  Occurrence of antibodies against chlamydial lipopolysaccharide in human sera as measured by ELISA using an artificial glycoconjugate antigen. , 1994, FEMS immunology and medical microbiology.

[18]  J. Yudkin,et al.  Microalbuminuria: associations with height and sex in non-diabetic subjects. , 1993, BMJ.

[19]  B. Spiegelman,et al.  IRS-1-Mediated Inhibition of Insulin Receptor Tyrosine Kinase Activity in TNF-α- and Obesity-Induced Insulin Resistance , 1996, Science.

[20]  J. Danesh,et al.  Chronic infections and coronary heart disease: is there a link? , 1997, The Lancet.

[21]  B. Spiegelman,et al.  Tumor Necrosis Factor α: A Key Component of the Obesity-Diabetes Link , 1994, Diabetes.

[22]  K. Feingold,et al.  Effects of endotoxin and cytokines on lipid metabolism. , 1994, Current opinion in lipidology.

[23]  F. Bandini,et al.  Chlamydia pneumoniae antibody response in patients with acute myocardial infarction and their follow-up. , 1998, American heart journal.

[24]  R. Nordan,et al.  Interleukin 6 reduces lipoprotein lipase activity in adipose tissue of mice in vivo and in 3T3-L1 adipocytes: a possible role for interleukin 6 in cancer cachexia. , 1992, Cancer research.

[25]  D. Stewart,et al.  Lack of role for nitric oxide (NO) in the selective destabilization of endothelial NO synthase mRNA by tumor necrosis factor-alpha. , 1995, Arteriosclerosis, thrombosis, and vascular biology.

[26]  A. Maseri,et al.  Inflammation in ischaemic heart disease , 1996, BMJ.

[27]  S. Thompson,et al.  Hemostatic factors and the risk of myocardial infarction or sudden death in patients with angina pectoris. European Concerted Action on Thrombosis and Disabilities Angina Pectoris Study Group. , 1995, The New England journal of medicine.

[28]  P. Rossing,et al.  Elevated fibrinogen and the relation to acute phase response in diabetic nephropathy. , 1996, Thrombosis research.

[29]  J. Van Snick.  Interleukin-6: an overview. , 1990, Annual review of immunology.

[30]  G. Ciliberto,et al.  Elevated levels of interleukin-6 in unstable angina. , 1996, Circulation.

[31]  M. Walker,et al.  Aromatase activity and interleukin-6 production by normal and malignant breast tissues. , 1995, The Journal of clinical endocrinology and metabolism.

[32]  L. Kuller,et al.  Lifetime smoking exposure affects the association of C-reactive protein with cardiovascular disease risk factors and subclinical disease in healthy elderly subjects. , 1997, Arteriosclerosis, thrombosis, and vascular biology.

[33]  J S Yudkin,et al.  Journal of Clinical Endocrinology and Metabolism Printed in U.S.A. Copyright © 1997 by The Endocrine Society Subcutaneous Adipose Tissue Releases Interleukin-6, But Not Tumor Necrosis Factor-�, in Vivo* , 2022 .

[34]  B. Spiegelman,et al.  Increased adipose tissue expression of tumor necrosis factor-alpha in human obesity and insulin resistance. , 1995, The Journal of clinical investigation.

[35]  J V Castell,et al.  Interleukin-6 and the acute phase response. , 1990, The Biochemical journal.

[36]  P. Vallance,et al.  Infection, inflammation, and infarction: does acute endothelial dysfunction provide a link? , 1997, The Lancet.

[37]  B. Spiegelman,et al.  Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance. , 1993, Science.

[38]  G. Ciliberto,et al.  Role of IL-6 and its soluble receptor in induction of chemokines and leukocyte recruitment. , 1997, Immunity.

[39]  Cotran Rs,et al.  The Pathogenesis of Atherosclerosis: Atherogenesis and Inflammation , 1989 .

[40]  R. Cotran,et al.  The pathogenesis of atherosclerosis: atherogenesis and inflammation. , 1988, Laboratory investigation; a journal of technical methods and pathology.

[41]  L. Kuller,et al.  Relation of C-reactive protein and coronary heart disease in the MRFIT nested case-control study. Multiple Risk Factor Intervention Trial. , 1996, American journal of epidemiology.

[42]  G. Reaven.  Role of Insulin Resistance in Human Disease , 1988, Diabetes.

[43]  A. Woolf,et al.  Elevated plasma levels of ED1+ ("cellular") fibronectin in patients with vascular injury. , 1989, The Journal of laboratory and clinical medicine.

[44]  D. Strachan,et al.  Relation of serum cytokine concentrations to cardiovascular risk factors and coronary heart disease. , 1997, Heart.

[45]  J. Yudkin,et al.  Longitudinal study of associations of microalbuminuria with the insulin resistance syndrome and sodium-lithium countertransport in nondiabetic subjects. , 1995, Arteriosclerosis, thrombosis, and vascular biology.

[46]  S. Thompson,et al.  Production of C-reactive protein and risk of coronary events in stable and unstable angina , 1997, The Lancet.

[47]  W. Weintraub,et al.  Elevation of C-reactive protein in "active" coronary artery disease. , 1990, The American journal of cardiology.

[48]  J. Stephens,et al.  Regulation of transcription factor mRNA accumulation during 3T3-L1 preadipocyte differentiation by tumour necrosis factor-alpha. , 1992, Journal of molecular endocrinology.

[49]  D. Strachan,et al.  Association of Helicobacter pylori and Chlamydia pneumoniae infections with coronary heart disease and cardiovascular risk factors , 1995, BMJ.